Skip to main content
Help
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Lockups
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
Analysts
News
Trending
Private Companies
Technical Chart
Fundamental Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Alebund Pharmaceuticals (Jiangsu) Limited (HKG:9637)
Hong Kong
· Delayed Price · Currency is HKD
Full Chart
Watchlist
Alerts
Compare
28.80
+0.30 (1.05%)
At close: Sep 4, 2026
Overview
Financials
Forecast
Statistics
History
Profile
Chart
Financials
Income Statement
Balance Sheet
Cash Flow
Ratios
Annual
Quarterly
TTM
HKG:9637 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Mil
Millions
Data
Data Source
CNY
CNY
More
Download
Full Width
Fiscal Year
FY 2025
FY 2024
Period Ending
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Net Income
-750.04
-326.03
Depreciation & Amortization
44.61
12.52
Other Amortization
0.13
0.03
Loss (Gain) From Sale of Assets
0.1
0
Loss (Gain) From Sale of Investments
-1.95
-
Loss (Gain) on Equity Investments
2.82
-0
Stock-Based Compensation
260.76
21.9
Other Operating Activities
108.66
16.02
Change in Accounts Receivable
0.87
-0.87
Change in Inventory
-4.15
-6.12
Change in Accounts Payable
74.06
4.13
Change in Unearned Revenue
9.02
30.77
Change in Other Net Operating Assets
-32.78
-2.26
Operating Cash Flow
-287.89
-249.9
Operating Cash Flow Growth
-
-
Investing Activities
Mil
Millions
Data
Data Source
CNY
CNY
More
Download
Full Width
Fiscal Year
FY 2025
FY 2024
Period Ending
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Capital Expenditures
-101.62
-230.63
Sale (Purchase) of Intangibles
-
-6.04
Investment in Securities
-148.38
-13.55
Other Investing Activities
13.18
-7.2
Investing Cash Flow
-236.82
-257.41
Financing Activities
Mil
Millions
Data
Data Source
CNY
CNY
More
Download
Full Width
Fiscal Year
FY 2025
FY 2024
Period Ending
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Short-Term Debt Issued
-
32.55
Long-Term Debt Issued
145.03
384.62
Total Debt Issued
145.03
417.18
Short-Term Debt Repaid
-
-528.83
Long-Term Debt Repaid
-118.05
-57.21
Total Debt Repaid
-118.05
-586.03
Net Debt Issued (Repaid)
26.97
-168.86
Issuance of Common Stock
535.78
1,345
Other Financing Activities
-21.04
-388.19
Financing Cash Flow
541.72
787.67
Net Cash Flow
Mil
Millions
Data
Data Source
CNY
CNY
More
Download
Full Width
Fiscal Year
FY 2025
FY 2024
Period Ending
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Foreign Exchange Rate Adjustments
-2.45
0.26
Net Cash Flow
14.56
280.62
Free Cash Flow
Mil
Millions
Data
Data Source
CNY
CNY
More
Download
Full Width
Fiscal Year
FY 2025
FY 2024
Period Ending
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Free Cash Flow
-389.51
-480.52
Free Cash Flow Growth
-
-
Free Cash Flow Margin
-1274.74%
-7364.34%
Free Cash Flow Per Share
-1.59
-1.77
Levered Free Cash Flow
-1,950
-
Unlevered Free Cash Flow
-1,881
-
Additional Metrics
Mil
Millions
Data
Data Source
CNY
CNY
More
Download
Full Width
Fiscal Year
FY 2025
FY 2024
Period Ending
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Cash Interest Paid
18.99
14.57
Change in Working Capital
47.02
25.66